Emad Raddaoui, MD, FCAP, FASC Associate Professor; Consultant Histopathology & Cytopathology.

Slides:



Advertisements
Similar presentations
Thyroid Cancer -- Papillary
Advertisements

Case 20 Thomas J. Giordano, M.D., Ph.D.. History A 54-year old man with a past medical history of goiter for approximately 4 years was followed by ultrasound.
APPROACH TO A CASE OF THYROID NODULE
Pathology of the thyroid. Derived from pharyngeal epithelium Descends from foramen cecum to lower neck Lingual thyroid or ectopic in neck 2 lobes and.
Thyroid Cancer May 10, 2006.
D3 Tambal – Tolentino THYROID CA.
Is the BRAF V600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer? The American Journal of Surgery.
Thyroid nodule History History Physical examination Physical examination –Euthyroid –Hypothyroid –Hyperthyroid Labs Labs –TSH –(antibodies)
Kentucky Cancer Registry Thyroid Cancer Overview
Update in the Management of Thyroid Neoplasms University of Washington
12 th G. Rainey Williams Surgical Symposium What Operation for Thyroid Cancer? Ronald Squires, MD FACS Associate Professor of Surgery Sections of General.
THYROID NODULES AND NEOPLASMS Emad Raddaoui, MD, FCAP, FASC Associate Professor; Consultant Histopathology & Cytopathology.
Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Approach.
Endocrine Pathology. Pituitary Gland Anterior Pituitary Anterior Pituitary HORMONS ?? Posterior Pituitary Posterior Pituitary HORMONS ??Diseases Non-neoplastic.
Thyroid Pathology Last Updated Oct. 5, 2006 Jamie Tibbo Reviewed with Dr. Jane Thomas.
Endocrinology CPC. History/Findings: The patient is a 25 year old concert violinist from Drogheda who presented with a 5 cm x 4 cm x 3 cm mass in the.
THYROID CANCER.
FNA of the Thyroid Lisa Kendrick BSc., RT Cytology, CT (ASCP) School of Diagnostic Cytology Health Sciences Centre.
Thyroid Cancer Dr. Awad Alqahtani Md,MSc.FRCSC(G.Surgery)FRCSC(Surgical Oncology) Laparoscopic and Bariatric Surgery.
THYROID GLAND.
B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b.
Vic V. Vernenkar, D.O. St. Barnabas Hospital Department of Surgery
Ian Jaffee, MD FCAP Director of Cytopathology
Thyroid nodules and neoplasms EMAD RADDAOUI, MD, FCAP, FASC ASSOCIATE PROFESSOR; CONSULTANT HISTOPATHOLOGY & CYTOPATHOLOGY.
THYROID TREATMENT AND VITAMIN D UPDATE A CPMC Regional CME Event - An Integrated Approach Saturday October 27, 2012.
Solitary thyroid nodule Hystory Low dose radiation Family hystory Physical exam.
Thyroid Cancer 2005 Nancy Fuller, M.D. University of Wisconsin-Madison.
ד"ר חגי מזא"ה כירורגיה אנדוקרינית מבואות כירורגיה שנה ד'
Approach to the Thyroid Nodule
Management of the Thyroid Nodule Neil S Tolley MD FRCS DLO St Mary’s Hospital 28 th February 2002.
Thyroid Nodules Hollis Moye Ray, MD SEAHEC Internal Medicine June 3, 2011.
Endocrine Pathology Lab
Breast Pathology Emad Raddaoui, MD, FCAP, FASC
A 75 y/o woman with Solitary hypo function cold nodule of upper pole of right lobe.
IMAGING OF THE THYROID Dr Jill Hunt Consultant Radiologist West Herts NHS Trust.
Endocrine system SYLLABUS: RBP(Robbins Basic Pathology) Chapter: The Endocrine System.
Evaluation of Thyroid Nodules
Endocrine practical block
Understanding Cancer and Related Topics
3. What work ups are needed, if any?
. IV. GRAVES DISEASE - Is the most common cause of endogenous hyperthyroidism with a peak incidence in women between the ages of 20 and 40 - It is characterized.
NEOPLASIA DELLA TIROIDE: INTRODUZIONE ANATOMO-PATOLOGICA ALL’ARGOMENTO
1. Clinical Impression? Differentials?. Thyroid Carcinoma commonly manifests as a painless, palpable, solitary thyroid nodule The patient's age at presentation.
What work ups are needed, if any?. MALIGNANT VS. BENIGN History taking Physical examination Fine-needle aspiration biopsy (FNAB) Other imaging and laboratory.
Endocrine practical block Dr Shaesta Naseem
Treatment of thyroid nodules Depends on: –FNA cytological examination –Uptake of radioiodine –Size and patient preferences.
Renal tumors-1 Dr. Abdelaty Shawky Assistant professor of pathology 1.
Thyroid nodules and neoplasms. Upon completion of this lecture the students will be able to: Understand the concept of diffuse and multinodular goiter.
Tumors of the Thyroid Gland
Oncology 2016 Mark D. Browning, M.D. ’77 Thyroid & Gastric Cancer
Dr.Bharathi Sengodan M.D.,. Thyroiditis Acute thyroiditis Bacterial infection (e.g., Staphylococcus aureus) Clinical findings (1) Fever (2) Tender gland.
In The Name Of God. Thyroid Nodules (Epidemiology;Etiology &Pathogenesis)
What is your clinical impression? What are the differential diagnosis?
Thyroid Cancer Incidence in Massachusetts, Richard Knowlton, MS Annie MacMillan, MPH Massachusetts Cancer Registry Massachusetts Department of.
Pathology of thyroid 3 Dr: Salah Ahmed. Follicular adenoma - are benign neoplasms derived from follicular epithelium - are usually solitary - the majority.
R2 Jaemin Kim/Prof. Seungjoon Oh Journal conference 1.

Thyroid tumors Dr. Gehan Mohamed.
Thyroid Neoplasms Dr. Amit Gupta Associate Professor Dept. of Surgery.
Medullary Thyroid Carcinoma
THYROID TUMORS.
MEDULLARY THYROID CANCER
Familial Thyroid Carcinoma
Quiz 7 Review Kristine Krafts, M.D.
NEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS
عنوان: بررسي فراواني انواع كانسرهاي تيروئيد از نظر زير گروه هيستوپاتولوژيك، توزيع سني، جنسي و محل آناتوميك آن در انستيتو كانسر و امام در طي سالهاي 1381.
Cheng-Chiao Huang, MD, MSc
Diseases of thyroid & parathyroid glands (2 of 2)
AMR Seminar Symposium Split, Croatia Case #63
Presentation transcript:

Emad Raddaoui, MD, FCAP, FASC Associate Professor; Consultant Histopathology & Cytopathology

 Objectives:  The student should: ▪ Know the definition of a solitary nodule in the thyroid. ▪ Recognize the differential diagnosis of a solitary thyroid nodule. ▪ Understand the classification, pathology and behavior of thyroid carcinoma.

 Palpably discrete swelling within an otherwise apparently normal thyroid gland.  Incidence : 1% and 10%.  Single nodules: F/M 4/1.  Incidence increases throughout life.  Majority : localized, non-neoplastic conditions or benign neoplasms such as follicular adenomas.  Benign neoplasms outnumber thyroid carcinomas by a ratio of nearly 10 : 1

Clues to the nature of a given thyroid nodule:  Solitary nodules : neoplastic  Nodules in younger patients : neoplastic  Nodules in males : neoplastic  A history of radiation : neoplastic  Nodules uptaking radioactive iodine (hot nodules) : benign

 Adenomas of the thyroid are typically discrete, solitary masses. (follicular adenomas) Degree of follicle formation and the colloid content of the follicles:  Simple colloid adenomas (macrofollicular adenomas)  A common form recapitulate stages in the embryogenesis of the normal thyroid (fetal or microfollicular, embryonal or trabecular).

 Careful evaluation of the integrity of the capsule is critical in distinguishing follicular adenomas from follicular carcinomas, which demonstrate capsular and/or vascular invasion

 Carcinomas of the thyroid : 1.5% of all cancers  Papillary carcinoma (> 85% of cases)  Follicular carcinoma (05% to 15% of cases)  Medullary carcinoma (5% of cases)  Anaplastic carcinoma (<5% of cases)

 Follicular Thyroid Carcinomas: mutations in the RAS family of oncogenes  Papillary Thyroid Carcinomas. rearrangements of the tyrosine kinase receptors RET or NTRK1 or activating point mutations in BRAF  Medullary Thyroid Carcinomas: Familial medullary thyroid carcinomas occur in multiple endocrine neoplasia type 2 (MEN-2) RET proto-oncogene mutation  Anaplastic Carcinomas: Inactivating point mutations in the p53 tumor suppressor gene are rare in well-differentiated thyroid carcinomas but common in anaplastic tumors.

 Environmental Factors. The major risk factor predisposing to thyroid cancer is exposure to ionizing radiation  Most often between the ages of 25 and 50  Majority of thyroid carcinomas associated with previous exposure to ionizing radiation.  The incidence of papillary carcinoma has increased markedly in the last 30 years  Solitary or multifocal lesions

 Papillary structures  Orphan Annie nuclei  Psammoma bodies  Pseudoinclusions  Grooved nuclei

 Tall cell variant  Hyalinizingtrabecular tumors ( ret/PTC gene rearrangement)  Follicular  Encapsulated  Diffuse sclerosing

 Most present as asymptomatic thyroid nodules.  The first manifestation may be a mass in a cervical lymph node.  Papillary thyroid cancers have an excellent prognosis.  Prognosis of PTC is dependent on several factors including age (in general, the prognosis is less favorable among patients older than 40 years), the presence of extra-thyroidal extension, and presence of distant metastases (stage).

 5% to 15% of primary thyroid cancers.  More common in women (3 : 1)  Peak incidence between 40 and 60 years.  More frequent in areas with dietary iodine deficiency

 Minimally invasive( well encapsulated), 10 year survival rate 90%.  Widely invasive carcinoma, 10 year survival rate less than 50%.

 Medullary carcinomas of the thyroid are neuroendocrine neoplasms derived from the parafollicular cells, or C cells, of the thyroid.

 Medullary carcinomas, similar to normal C cells, secrete calcitonin, the measurement of which plays an important role in the diagnosis and postoperative follow-up of patients.  About 70% of tumors arise sporadically.  The remainder occurs in the setting of MEN syndrome 2A or 2B or as  Familial tumors without an associated MEN syndrome (familial medullary thyroid carcinoma, or FMTC)

 Polygonal to spindle cells  Amyloid deposition  Bilaterality  Multicentricity  Necrosis  Hemorrhage

 Anaplastic carcinomas of the thyroid are undifferentiated tumors of the thyroid follicular epithelium.  Can be arising from a more differentiated carcinoma (papillary)  Lethal (100%)  Older age group > 65 year

Highly anaplastic cells: (1) large, pleomorphicgiant cells, including occasional osteoclast-like multinucleate giant cells (2) spindle cells with a sarcomatous appearance (3) mixed spindle and giant cells (4) small cells